null

Imalumab Biosimilar (Anti-MIF) Antibody (HDBS0087)

SKU:
HDBS0087
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
MIF
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399

Description

system_update_altDatasheet

Imalumab (Anti-MIF) Biosimilar Antibody (HDBS0087)

The Imalumab biosimilar Anti-MIF Antibody is a cutting-edge product designed for research involving MIF (Macrophage Migration Inhibitory Factor), a pro-inflammatory cytokine with a crucial role in immune regulation. The antibody is produced using advanced biosimilar technology to target MIF specifically, enabling precise detection and analysis in various cell types.With its highly reactive nature towards human samples, this antibody is ideal for studies in immunology, inflammation, and autoimmune disorders. Its validation for use in various applications, such as ELISA and immunofluorescence, makes it a versatile tool for researchers seeking to unravel the complex mechanisms of immune response modulation and inflammatory pathways involving MIF.

By targeting MIF, a key player in the immune system's response to infection, inflammation, and autoimmune diseases, this antibody opens up new possibilities for therapeutic interventions and drug development. Its potential applications in cancer research and chronic inflammatory conditions make it a valuable asset in the quest for novel treatments and personalized medicine approaches. Unlock the potential of MIF research with the Imalumab biosimilar Anti-MIF Antibody.